News | May 11, 2021
Alembic reports net profit of Rs. 71.94 Cr in Q4FY21
Alembic has reported total income of Rs.83.79 crores during the FY ended March 31, 2021
Alembic has reported total income of Rs.83.79 crores during the FY ended March 31, 2021
The drug accumulates in the virus infected cells and prevents virus growth by stopping viral synthesis and energy production
Glucon-D, Sugar Free, EverYuth Scrub, Peel Off Face Mask and Nycil maintained their leadership positions in-their respective categories as on March 2021.
Dorzolamide Hydrochloride and Timolol Maleate Ophthalmic Solution USP, 2% and 0.5% has an estimated market size of US $80 million for twelve months ending December 2020 according to IQVIA
R&D Centre will be housed in Baddi and will cater to all business divisions in addition to expansion plans for all its verticals including APls, Formulations and Medical Devices
Gujarat Themis Biosyn has reported total income of Rs.93.82 crores for FY 2020-21
The companyreported total income of Rs.2915.67 crores during the 12 months period ended March 31, 2021
This oxygen is being provided free-of-cost to several state governments across the country to bring immediate relief to over 1 lakh patients on a daily basis
Dr. Reddy’s Albendazole Tablets, USP are available in 200 mg tablets in bottle count sizes of two
New agreement for three further production lines at Lonza’s site in Visp, Switzerland
Subscribe To Our Newsletter & Stay Updated
